0.1990
+0.0180
+(9.94%)
As of 12:04:45 PM GMT+1. Market Open.
Breakdown
TTM
5/31/2024
5/31/2023
5/31/2022
5/31/2021
Operating Cash Flow
-2,131.0000
-10,982.0000
-25,110.0000
-77,723.0000
-117,573.0000
Investing Cash Flow
--
--
--
--
-122.0000
Financing Cash Flow
16,742.0000
11,748.0000
29,927.0000
48,011.0000
137,346.0000
End Cash Position
21,335.0000
9,814.0000
9,048.0000
4,231.0000
33,943.0000
Interest Paid Supplemental Data
30.0000
45.0000
19.0000
63.0000
147.0000
Capital Expenditure
--
--
--
--
-122.0000
Issuance of Capital Stock
6,121.0000
9,137.0000
25,786.0000
41,195.0000
1,000.0000
Issuance of Debt
654.0000
2,011.0000
895.0000
--
100,000.0000
Repayment of Debt
--
--
--
--
-950.0000
Free Cash Flow
-2,131.0000
-10,982.0000
-25,110.0000
-77,723.0000
-117,695.0000
5/31/2021 - 6/5/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ENGN enGene Holdings Inc.
6.74
-5.06%
RYTM Rhythm Pharmaceuticals, Inc.
59.52
+0.51%
NRIX Nurix Therapeutics, Inc.
19.71
-1.52%
ABSI Absci Corporation
3.7000
-3.15%
EYEN Eyenovia, Inc.
0.0348
-0.29%
NTLA Intellia Therapeutics, Inc.
10.38
-1.24%
ATHE Alterity Therapeutics Limited
4.9300
+7.88%
REGN Regeneron Pharmaceuticals, Inc.
674.94
-1.19%
RXRX Recursion Pharmaceuticals, Inc.
7.32
-4.88%
TNXP Tonix Pharmaceuticals Holding Corp.
0.4279
+14.07%